Bluemoor Health reports quarterly revenue above the internal plan
Bluemoor Health said demand in its Medical Devices segment held up through the quarter, with management reiterating full-year margin guidance.
Terminal Brief
Bluemoor Health
Healthcare · Medical Devices
Updated UTC
US$146,21
+1,91+1,32%
After hoursUS$145,56-0,44%
| Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | 12,63 M | 14,13 M | 15,19 M | 15,96 M | 17,26 M |
| Gross profit | 7,23 M | 8,43 M | 8,68 M | 9,28 M | 10,31 M |
| Operating income | 2,62 M | 3,12 M | 3,2 M | 2,99 M | 3,14 M |
| Net income | 1,87 M | 1,82 M | 2,38 M | 2,03 M | 2,49 M |
Develops remote-monitoring hardware and clinical software for chronic-care providers.
Bluemoor Health said demand in its Medical Devices segment held up through the quarter, with management reiterating full-year margin guidance.
Terminal Brief
The company approved a multi-year capital program intended to shorten lead times for its largest customers.
Market Wire
A sell-side desk kept a neutral rating while noting that near-term estimates already reflect steady execution.
Sector Desk
The board named an internal candidate with prior treasury and investor-relations experience to the role.
Market Wire
The authorization covers a modest slice of the float and will be funded from operating cash flow.
Market Wire